Delivery Order SPE2DR25D2206-SPE2DR26F9EQ2
- Not listed
- The Defense Logistics Agency awarded a Delivery Order valued at $5,789.98 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on November 17, 2025, with completion expected by November 18, 2025. This firm fixed-price, non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $13,174.36 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a completion date of December 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a pediatric or standard pharmaceutical delivery within the agency's medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a ceiling value of $1,053.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is set for ultimate completion by December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a $10,538.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on July 2, 2025, with completion scheduled for July 3, 2025. This non-set-aside award represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,392.79 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on August 15, 2025, with completion expected by August 18, 2025. This firm fixed price, non-set-aside delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs,...
- The Defense Logistics Agency awarded a $1,550.97 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen medication on November 10, 2025, with completion targeted for November 12, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,078.40 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9EQ2Delivery Order
The Defense Logistics Agency awarded a $10,205.97 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on December 5, 2025, with completion expected by December 8, 2025. This competitively awarded, firm fixed-price delivery order represents pharmaceutical supply for federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle functions as a comprehensive global pharmaceutical support mechanism, enabling the company to supply a diverse range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities for customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 12/4/25 |